Our Posts...

May 24, 2016

A major conference on hepatitis treatment heard lots more good news about the new drugs for hepatitis C. For example, a single pill combining sofosbuvir with the new drug velpatasvir cured 95% of people living with hepatitis C and HIV co-infection. Results were similar regardless of hepatitis C genotype (1 to 4), the presence or absence of cirrhosis, and whether people had taken hepatitis treatment before or not.

But how many people in the UK will be able to access this new medicine and others like it? The situation is better in Scotland, but NHS England’s guidelines are so restrictive that the new generation of hepatitis C drugs are often only available to people who are already seriously ill with hepatitis C.

Faced with situations like this...

Please reload

Featured Posts

HIV transmission and antiretroviral therapy

May 24, 2016

Please reload

Recent Posts
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Classic
  • Twitter Classic

Registered Charity 1129248

Company by Guarantee 06772710

Website developed K Bennett, Template © 2023 by PERSONAL TRAINER with Wix.com